Strides Pharma Science Limited (NSE:STAR)
India flag India · Delayed Price · Currency is INR
784.10
-5.70 (-0.72%)
Jun 6, 2025, 1:30 PM IST

Strides Pharma Science Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Revenue
45,65340,51136,88430,70333,159
Upgrade
Revenue Growth (YoY)
12.69%9.84%20.13%-7.41%20.49%
Upgrade
Cost of Revenue
19,80018,09817,58016,13614,214
Upgrade
Gross Profit
25,85422,41319,30414,56618,945
Upgrade
Selling, General & Admin
8,6288,0347,6866,7285,704
Upgrade
Other Operating Expenses
9,1987,0257,7467,8816,896
Upgrade
Operating Expenses
19,74817,26617,86416,93914,662
Upgrade
Operating Income
6,1065,1471,439-2,3734,282
Upgrade
Interest Expense
-2,489-2,727-2,176-1,457-1,244
Upgrade
Interest & Investment Income
-304.29745.281,076364.94
Upgrade
Earnings From Equity Investments
18.37-1,757-2,853-1,108-978.19
Upgrade
Currency Exchange Gain (Loss)
-96.41448.88-97.8480.17
Upgrade
Other Non Operating Income (Expenses)
587.22-357.45-345.98-239.31-215.14
Upgrade
EBT Excluding Unusual Items
4,223705.93-2,741-4,1992,290
Upgrade
Merger & Restructuring Charges
1,071-30.8469.56-2,145-23.61
Upgrade
Gain (Loss) on Sale of Investments
---0.04-
Upgrade
Gain (Loss) on Sale of Assets
-14.3241.07112.4723.38
Upgrade
Asset Writedown
-0.05-1,575-330.4-46.76-
Upgrade
Other Unusual Items
-424.02-283.83-301.08-246.06464.59
Upgrade
Pretax Income
4,869-1,169-2,862-6,5252,754
Upgrade
Income Tax Expense
775.16315.9-553.01-1,783316.51
Upgrade
Earnings From Continuing Operations
4,094-1,485-2,309-4,7432,438
Upgrade
Earnings From Discontinued Operations
31,881542.2185.69-139.41
Upgrade
Net Income to Company
35,975-943.14-2,123-4,7432,577
Upgrade
Minority Interest in Earnings
-40.5723796.95140.39107.13
Upgrade
Net Income
35,935-706.14-2,026-4,6022,684
Upgrade
Net Income to Common
35,935-706.14-2,026-4,6022,684
Upgrade
Net Income Growth
----637.66%
Upgrade
Shares Outstanding (Basic)
9291909090
Upgrade
Shares Outstanding (Diluted)
9291909090
Upgrade
Shares Change (YoY)
1.12%1.02%0.37%0.04%0.14%
Upgrade
EPS (Basic)
390.55-7.76-22.49-51.2829.96
Upgrade
EPS (Diluted)
390.50-7.76-22.50-51.2829.92
Upgrade
EPS Growth
----637.04%
Upgrade
Free Cash Flow
4,4195,829-505.27-4,0121,840
Upgrade
Free Cash Flow Per Share
48.0264.06-5.61-44.7020.50
Upgrade
Dividend Per Share
4.0002.5001.500-2.500
Upgrade
Dividend Growth
60.00%66.67%--25.00%
Upgrade
Gross Margin
56.63%55.33%52.34%47.44%57.13%
Upgrade
Operating Margin
13.37%12.71%3.90%-7.73%12.91%
Upgrade
Profit Margin
78.71%-1.74%-5.49%-14.99%8.10%
Upgrade
Free Cash Flow Margin
9.68%14.39%-1.37%-13.07%5.55%
Upgrade
EBITDA
8,0286,9093,403-494.55,942
Upgrade
EBITDA Margin
17.59%17.05%9.23%-1.61%17.92%
Upgrade
D&A For EBITDA
1,9231,7621,9641,8791,660
Upgrade
EBIT
6,1065,1471,439-2,3734,282
Upgrade
EBIT Margin
13.37%12.71%3.90%-7.73%12.91%
Upgrade
Effective Tax Rate
15.92%---11.49%
Upgrade
Revenue as Reported
46,24140,90837,78732,02233,673
Upgrade
Advertising Expenses
-365.3221.73178.18130.48
Upgrade
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.